Fate Therapeutics Inc (NASDAQ:FATE) traded at $1.30 at close of the session on Monday, June 02 and made an upward move of 7.44% on its previous day’s price. Fate Therapeutics Inc has a market cap of $149.02 million and is expected to release its quarterly
Fate Therapeutics Inc (NASDAQ:FATE) shares, rose in value, with the stock price up by 4.10% to the previous day’s close as strong demand from buyers drove the stock to $1.27. Actively observing the price movement in the last trading, the stock closed the session at
Fate Therapeutics Inc (NASDAQ:FATE) traded at $1.07 at close of the session on Monday, May 12 and made an upward move of 2.88% on its previous day’s price. Fate Therapeutics Inc has a market cap of $122.62 million and is expected to release its quarterly
The trading price of Fate Therapeutics Inc (NASDAQ:FATE) closed lower on Tuesday, May 06, and closing at $0.96, -18.14% lower than its previous close. In examining the 52-week price action we see that the stock hit a 52-week high of $5.92 and a 52-week low
The trading price of Fate Therapeutics Inc (NASDAQ:FATE) floating lower at last check on current market day and closing at $1.23, -6.49% lower than its previous close. Traders who pay close attention to intraday price movement should know that it has been fluctuating between $1.22
Fate Therapeutics Inc (NASDAQ:FATE) price closed lower on Tuesday, April 29, and dropping -6.40% below its previous close. A look at the daily price movement shows that the last close reads $1.25, with intraday deals fluctuated between $1.15 and $1.27. The company’s 5Y monthly beta
Stocks Register is a comprehensive online news hub delivering daily updates on various facets of U.S. life, including business, technology, politics, economy, culture, sports, and noteworthy global events.